DE69032613T2 - Zusammensetzung und verfahren zur behandlung viraler infektionen - Google Patents

Zusammensetzung und verfahren zur behandlung viraler infektionen

Info

Publication number
DE69032613T2
DE69032613T2 DE69032613T DE69032613T DE69032613T2 DE 69032613 T2 DE69032613 T2 DE 69032613T2 DE 69032613 T DE69032613 T DE 69032613T DE 69032613 T DE69032613 T DE 69032613T DE 69032613 T2 DE69032613 T2 DE 69032613T2
Authority
DE
Germany
Prior art keywords
composition
viral infections
treating viral
agents
homologs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69032613T
Other languages
English (en)
Other versions
DE69032613D1 (de
Inventor
Daniel Meruelo
Gad Lavie
Yehuda Mazur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
New York University NYU
Original Assignee
Yeda Research and Development Co Ltd
New York University NYU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd, New York University NYU filed Critical Yeda Research and Development Co Ltd
Application granted granted Critical
Publication of DE69032613D1 publication Critical patent/DE69032613D1/de
Publication of DE69032613T2 publication Critical patent/DE69032613T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69032613T 1989-03-16 1990-03-16 Zusammensetzung und verfahren zur behandlung viraler infektionen Expired - Fee Related DE69032613T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32417789A 1989-03-16 1989-03-16
US41716389A 1989-10-04 1989-10-04
US48851890A 1990-02-27 1990-02-27
PCT/US1990/001463 WO1990010438A1 (en) 1989-03-16 1990-03-16 Compositions and methods for treating viral infections

Publications (2)

Publication Number Publication Date
DE69032613D1 DE69032613D1 (de) 1998-10-08
DE69032613T2 true DE69032613T2 (de) 1999-02-25

Family

ID=27406317

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69032613T Expired - Fee Related DE69032613T2 (de) 1989-03-16 1990-03-16 Zusammensetzung und verfahren zur behandlung viraler infektionen

Country Status (11)

Country Link
US (1) US6150414A (de)
EP (1) EP0426785B1 (de)
JP (1) JPH04504849A (de)
AT (1) ATE170399T1 (de)
AU (1) AU640131B2 (de)
CA (1) CA2029863C (de)
DE (1) DE69032613T2 (de)
DK (1) DK0426785T3 (de)
ES (1) ES2123499T3 (de)
IL (1) IL93682A (de)
WO (1) WO1990010438A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992018123A2 (en) * 1991-04-10 1992-10-29 Octamer, Inc. A method for inhibition of retroviral replication
US6576784B1 (en) * 1993-05-27 2003-06-10 Yeda Research And Development Co. Ltd. Antiviral agents
IL121440A0 (en) 1997-07-31 1998-01-04 Yeda Res & Dev The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
EP1141314A2 (de) 1998-12-31 2001-10-10 Chiron Corporation Für antigene polypeptide des hiv type c kodierende polynukleotide, entsprechende polypeptide und verwendungen davon
ATE384795T1 (de) 1998-12-31 2008-02-15 Novartis Vaccines & Diagnostic Modifizierte hiv env polypeptide
CA2360347C (en) 1998-12-31 2013-05-07 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
WO2001056558A1 (en) * 2000-01-31 2001-08-09 Yeda Research And Development Co. Ltd. Polycyclic dianthraquinones as anti-cancer and anti-angiogenic agents
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
AU2002316578A1 (en) 2001-08-31 2003-03-18 Chiron Corporation Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
JP4076749B2 (ja) * 2001-10-15 2008-04-16 富士フイルム株式会社 導電性有機化合物及び電子素子
US20180280321A1 (en) * 2015-03-12 2018-10-04 The Office Of Innovation Commercialization Compositions and methods that inhibit quorum sensing
SG11201807454YA (en) * 2016-03-01 2018-09-27 Soligenix Inc Systems and methods for producing synthetic hypericin
AU2018374389A1 (en) 2017-11-30 2020-05-07 Arrakis Therapeutics, Inc. Nucleic acid-binding photoprobes and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2707704A (en) * 1951-09-29 1955-05-03 Schenley Ind Inc Process for the preparation of hypericin
US3974186A (en) * 1970-05-14 1976-08-10 Richardson-Merrell Inc. Bis-basic ethers of 2,6- and 2,7-dihydroxyanthraquinones
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
US4670265A (en) * 1983-07-22 1987-06-02 Sydiskis Robert J Aloe emodin and other anthraquinones and anthraquinone-like compounds from plants virucidal against herpes simplex viruses
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
JPS62501712A (ja) * 1985-08-26 1987-07-09 アメリカ合衆国 ２′、３′―ジデオキシイノシン、２′，３′―ジデオキシグアノシンまたは２′，３′―ジデオキシアデノシンを含有する抗ｈｔｌｖ―３／ｌａｖ剤
IL79661A (en) * 1986-08-08 1991-01-31 Yeda Res & Dev Antiviral composition containing hypericin or pseudohypericin
US4898891A (en) * 1987-08-07 1990-02-06 Yeda Research And Development Company Ltd. Antiviral compositions
JP2725813B2 (ja) * 1987-08-10 1998-03-11 ニューヨーク ユニバーシィティ 芳香族多環式ジオンを含有する抗ウイルス性薬剤及びレトロウイルス感染治療方法
AU3294289A (en) * 1988-03-23 1989-10-16 New York University Antiviral composition containing aromatic polycyclic diones and nucleoside analogs and method for treating retrovirus infections
JPH0244231A (ja) * 1988-08-04 1990-02-14 Fuji Electric Co Ltd 中和滴定装置

Also Published As

Publication number Publication date
EP0426785B1 (de) 1998-09-02
AU640131B2 (en) 1993-08-19
DK0426785T3 (da) 1999-05-31
ES2123499T3 (es) 1999-01-16
JPH04504849A (ja) 1992-08-27
IL93682A (en) 1996-06-18
CA2029863A1 (en) 1990-09-17
EP0426785A4 (en) 1991-11-13
WO1990010438A1 (en) 1990-09-20
AU5338790A (en) 1990-10-09
ATE170399T1 (de) 1998-09-15
US6150414A (en) 2000-11-21
EP0426785A1 (de) 1991-05-15
CA2029863C (en) 2001-10-30
DE69032613D1 (de) 1998-10-08

Similar Documents

Publication Publication Date Title
ATE170399T1 (de) Zusammensetzung und verfahren zur behandlung viraler infektionen
BR9913157A (pt) Processos para tratar ou previnir infecção causada por pelo menos um vìrus das flaviviridae e doenças associadas com a referida infecção e infecção causada por pelo menos um vìrus do gênero hepacivìrus da flaviviridade e doenças associadas com a referida infecção, composição farmacêutica para tratar ou previnir infecções virais, e, composto
EA199901031A1 (ru) Производные бензимидазола
DK0473671T3 (da) Anvendelse af sigma-receptorligander til fremstilling af et anxiolytisk middel
HN1998000074A (es) Derivados de macrolidos c-4 sustituidos
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
MX23889A (es) Derivados de cromanos y tiocromanos, procedimiento para su preparacion y composicion farmaceutica.
ES2137225T3 (es) Eliminacion de anticuerpos de composiciones de derivados sanguineos reteniendo los factores de coagulacion.
DK0556332T3 (da) Substituerede tetrahydropyridiner og hydroxypiperidiner som midler til behandling af centralnervesystemet
UA45942A (uk) 1,3-оксатіолан, його похідні, спосіб (варіанти) його одержання та фармацевтична композиція
DK0556329T3 (da) Substituerede piperaziner som midler til behandling af centralnervesystemet
ES2174921T3 (es) Inhibidores de la proteasa del vih.
DE59710517D1 (de) Adamantanaminenderivate zur bekämpfung von viren der familie bornaviridae
DE69029693D1 (de) Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz
EP0594795A4 (de) Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren.
BR9909870A (pt) Pirrolidinas como inibidores de neuraminidases
DK0431579T3 (da) Substituerede cyclohexener som midler med virkning på centralnervesystemet
FI943850A0 (fi) 3-alkyylioksi-, aryylioksi- tai aryylialkyylioksibentso(b)tiofeeni-2-karboksamidit soluadheesion inhibiittoreina
DE3881864D1 (de) Antivirale zusammensetzungen mit aromatischen polycyclischen dionen sowie methode zur behandlung retroviraler infektionen.
MX9300008A (es) Nucleosidos terapeuticos.
ATE247672T1 (de) Zusammensetzung und diese enthaltende pharmazeutische zubereitung für die behandlung von herpes und verwandten viralen infektionen
EA200001028A1 (ru) Производные 2"-деоксигигромицина
ATE135232T1 (de) Pharmazeutische zusammensetzungen zur behandlung von b-zell-entartungen
ES2062266T3 (es) Uso de quinolil- e isoquinoliloxazol-2-onas para la obtencion de un medicamento destinado para la prevencion de infecciones por virus envueltos por glicoproteinas.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee